Literature DB >> 6137640

Treatment of ulcerative colitis with oral 5-aminosalicyclic acid in patients unable to take sulphasalazine.

M J Dew, A D Harries, B K Evans, J Rhodes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6137640     DOI: 10.1016/s0140-6736(83)92341-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Mesalazine is safe for the treatment of IBD.

Authors:  G D'Haens; A A van Bodegraven
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

Review 2.  Drug therapy of ulcerative colitis.

Authors:  B Crotty; D P Jewell
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

3.  Acute pancreatitis during oral 5-aminosalicylic acid therapy.

Authors:  M T Fiorentini; M Fracchia; G Galatola; A Barlotta; M de la Pierre
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

Review 4.  Acute pancreatitis secondary to 5-aminosalicylic acid therapy in a patient with ulcerative colitis.

Authors:  E Adachi; K Okazaki; Y Matsushima; H Seno; K Uchida; H Nakase; C Kawanami; T Nakamura; T Chiba
Journal:  Int J Pancreatol       Date:  1999-06

Review 5.  Inflammatory bowel disease in pregnancy: a review.

Authors:  J P Miller
Journal:  J R Soc Med       Date:  1986-04       Impact factor: 5.344

Review 6.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

7.  Salicylate induced exacerbation of ulcerative colitis.

Authors:  T K Chakraborty; D Bhatia; R C Heading; M J Ford
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

8.  Comparison of the absorption and metabolism of sulphasalazine and acrylic-coated 5-amino salicylic acid in normal subjects and patients with colitis.

Authors:  M J Dew; P Ebden; N S Kidwai; G Lee; B K Evans; J Rhodes
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

9.  Effect of polymer coating on faecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitis.

Authors:  H A Mardini; D C Lindsay; C M Deighton; C O Record
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

10.  Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution.

Authors:  S A Riley; J Lecarpentier; V Mani; M J Goodman; B K Mandal; L A Turnberg
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.